The latest news & stories from the Providence Research Network
-
Read ArticleLeading US health systems launch the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science
The Truveta Genome Project will enable scientists to transform how diseases are prevented, diagnosed and cured.
-
Read ArticleCORE selected to evaluate Oregon's ContraceptiveCare program
The Oregon Health Authority has selected Providence CORE to evaluate the next phase of Oregon's ContraceptiveCare (CCare) program.
-
Read ArticleCAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
-
Read ArticleHow immunotherapy is changing the fight against advanced endometrial cancer
Thanks in part to the work of gynecologic oncology researchers at Providence, healthcare providers and patients nationwide have a new standard of care for advanced or recurrent endometrial cancer.
-
Read ArticleTwo clinical trials for solid tumor cancers take different approaches to stop growth
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
-
Read ArticleComprehensive Genomic Profiling leads to better patient outcomes, new joint study says
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
-
Read ArticleLeadership change at Providence Cancer Institute, #FINISHCANCER goal remains
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
-
Read Article2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
-
Read ArticleHarnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
-
Read ArticleNew studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
-
Read ArticleProstate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
-
Read ArticleThe connection between dysautonomia and long COVID
Learn about dysautonomia, its symptoms, and how it's connected to long COVID. Discover treatment options and expert insights at Providence.
-
Read ArticleCan a community & health system partnership improve Black birth outcomes?
A research collaboration between CORE, PSU researcher Dr. Roberta Hunte and the Healthy Birth Initiative (HBI), is studying the impact of a cross-sector partnership on Black maternal health outcomes.
-
Read ArticlePersonalized cancer peptide vaccine shows remarkable promise against glioblastoma
A novel peptide vaccine against glioblastoma, a deadly brain tumor, is offering hope to some patients thanks to the work of an international effort including Providence's Santosh Kesari, MD, PhD.
-
Read ArticleDr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
-
Read ArticleProvidence Swedish team successfully implants first-of-its-kind device for heart valve repair
The procedure using the new TriClip to repair a leaky tricuspid valve was also a first in the Pacific Northwest.
-
Read ArticleDr. Bernard Fox honored for his lifetime contributions to cancer research
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
-
Read ArticleExamining the efficacy and safety of weight loss medications in the real world
A first-of-its-kind study on the efficacy and safety of weight loss medications in the real world is helping to provide clinicians with new is helping to provide clinicians with valuable new evidence.
-
Read ArticleSt. Pat's only one of five global sites for groundbreaking APOLLO research trial
-
Read ArticlePromising advances in treating TNBC: Two studies offer hope
Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.
-
Loading More...
